Search Results - "LIU, Stanley K"

Molecular landmarks of tumor hypoxia across cancer types by Bhandari, Vinayak, Hoey, Christianne, Liu, Lydia Y., Lalonde, Emilie, Ray, Jessica, Livingstone, Julie, Lesurf, Robert, Shiah, Yu-Jia, Vujcic, Tina, Huang, Xiaoyong, Espiritu, Shadrielle M. G., Heisler, Lawrence E., Yousif, Fouad, Huang, Vincent, Yamaguchi, Takafumi N., Yao, Cindy Q., Sabelnykova, Veronica Y., Fraser, Michael, Chua, Melvin L. K., van der Kwast, Theodorus, Liu, Stanley K., Boutros, Paul C., Bristow, Robert G.

“…Many primary-tumor subregions have low levels of molecular oxygen, termed hypoxia. Hypoxic tumors are at elevated risk for local failure and distant…”
Get full text

PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell Carcinoma by Hodgson, Anjelica, Slodkowska, Elzbieta, Jungbluth, Achim, Liu, Stanley K, Vesprini, Danny, Enepekides, Danny, Higgins, Kevin, Katabi, Nora, Xu, Bin, Downes, Michelle R

“…Programmed death ligand-1 (PD-L1) immunohistochemistry is used to guide treatment decisions regarding the use of checkpoint immunotherapy in the management of…”
Get full text

Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis by Mesci, Aruz, Huang, Xiaoyong, Taeb, Samira, Jahangiri, Sahar, Kim, Yohan, Fokas, Emmanouil, Bruce, Jeff, Leong, Hon S, Liu, Stanley K

“…Background: MicroRNAs (miRs) are involved in the regulation of many processes that contribute to malignancy, including cell proliferation, radiation…”
Get full text

microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation by Labbé, Maureen, Hoey, Christianne, Ray, Jessica, Potiron, Vincent, Supiot, Stéphane, Liu, Stanley K, Fradin, Delphine

“…As the most frequently diagnosed non-skin cancer in men and a leading cause of cancer-related death, understanding the molecular mechanisms that drive…”
Get full text

miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1 by XIAOYONG HUANG, TAEB, Samira, BRISTOW, Robert G, LIU, Fei-Fei, LIU, Stanley K, JAHANGIRI, Sahar, EMMENEGGER, Urban, TRAN, Elisa, BRUCE, Jeff, MESCI, Aruz, KORPELA, Elina, VESPRINI, Danny, SHUN WONG, C

“…Radiation resistance poses a major clinical challenge in cancer treatment, but little is known about how microRNA (miR) may regulate this phenomenon. In this…”
Get full text

Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomes by Khoo, Amanda, Govindarajan, Meinusha, Qiu, Zhuyu, Liu, Lydia Y., Ignatchenko, Vladimir, Waas, Matthew, Macklin, Andrew, Keszei, Alexander, Neu, Sarah, Main, Brian P., Yang, Lifang, Lance, Raymond S., Downes, Michelle R., Semmes, O. John, Vesprini, Danny, Liu, Stanley K., Nyalwidhe, Julius O., Boutros, Paul C., Kislinger, Thomas

“…Urine is a complex biofluid that reflects both overall physiologic state and the state of the genitourinary tissues through which it passes. It contains both…”
Get full text

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter? by Correa, Rohann J.M., Morton, Gerard, Chung, Hans T., Tseng, Chia-Lin, Cheung, Patrick, Chu, William, Liu, Stanley K, McGuffin, Merrylee, Shahid, Anam, Davidson, Melanie, Ravi, Ananth, Helou, Joelle, Alayed, Yasir, Zhang, Liying, Mamedov, Alexandre, Loblaw, Andrew

“…•PSA kinetics and biochemical failure were similar with two-fractions of SABR or HDR.•Quality of life, acute and late toxicities were no different in the two…”
Get full text

miRNA‐106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation by Hoey, Christianne, Ray, Jessica, Jeon, Jouhyun, Huang, Xiaoyong, Taeb, Samira, Ylanko, Jarkko, Andrews, David W., Boutros, Paul C., Liu, Stanley K.

“…Recurrence of high‐grade prostate cancer after radiotherapy is a significant clinical problem, resulting in increased morbidity and reduced patient survival…”
Get full text

RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer by Mesci, Aruz, Lucien, Fabrice, Huang, Xiaoyong, Wang, Eric H, Shin, David, Meringer, Michelle, Hoey, Christianne, Ray, Jessica, Boutros, Paul C, Leong, Hon S, Liu, Stanley K

“…While prostate cancer can often manifest as an indolent disease, the development of locally-advanced or metastatic disease can cause significant morbidity or…”
Get full text

Highly-Sensitive Amplification-Free Analysis of Multiple miRNAs by Capillary Electrophoresis by Wegman, David W, Ghasemi, Farhad, Khorshidi, Anna, Yang, Burton B, Liu, Stanley K, Yousef, George M, Krylov, Sergey N

“…Sets of deregulated microRNAs (miRNAs), termed miRNA signatures, are promising biomarkers for cancer. Validation of miRNA signatures requires a technique that…”
Get full text

Dll4-notch signalling blockade synergizes combined ultrasound-stimulated microbubble and radiation therapy in human colon cancer xenografts by El Kaffas, Ahmed, Nofiele, Joris, Giles, Anoja, Cho, Song, Liu, Stanley K, Czarnota, Gregory J

“…Tumour vasculature acts as an essential lifeline for tumour progression and facilitates metastatic spread. Novel vascular targeting strategies aiming to…”
Get full text

Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma by Mesci, Aruz, Taeb, Samira, Huang, Xiaoyong, Jairath, Rishi, Sivaloganathan, Darshan, Liu, Stanley K

“…AIM:To investigate the function of Pea3 in colorectal carcinoma(CRC)invasion and metastatic potential.METHODS:The expression of Pea3 during clinical…”
Get full text

Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials by Glicksman, Rachel M., Loblaw, Andrew, Morton, Gerard, Vesprini, Danny, Szumacher, Ewa, Chung, Hans T., Chu, William, Liu, Stanley K., Tseng, Chia-Lin, Davidson, Melanie, Deabreu, Andrea, Mamedov, Alexandre, Zhang, Liying, Cheung, Patrick

“…•Three prospective trials evaluating elective nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and convetionally…”
Get full text

Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer by Gavin Frame, Hon Leong, Roni Haas, Xiaoyong Huang, Jessica Wright, Urban Emmenegger, Michelle Downes, Paul C. Boutros, Thomas Kislinger, Stanley K. Liu

“…Abstract Background Metastatic relapse of prostate cancer after radiotherapy is a significant cause of prostate cancer-related morbidity and mortality. PLOD2…”
Get full text

Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancer by Paczkowski, Marcin, Kretzschmar, Warren W., Markelc, Bostjan, Liu, Stanley K., Kunz-Schughart, Leoni A., Harris, Adrian L., Partridge, Mike, Byrne, Helen M., Kannan, Pavitra

“…Intratumoural heterogeneity (ITH) contributes to local recurrence following radiotherapy in prostate cancer. Recent studies also show that ecological…”
Get full text

Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial by Sahgal, Arjun, Myrehaug, Sten D, Siva, Shankar, Masucci, Giuseppina L, Maralani, Pejman J, Brundage, Michael, Butler, James, Chow, Edward, Fehlings, Michael G, Foote, Mathew, Gabos, Zsolt, Greenspoon, Jeffrey, Kerba, Marc, Lee, Young, Liu, Mitchell, Liu, Stanley K, Thibault, Isabelle, Wong, Rebecca K, Hum, Maaike, Ding, Keyue, Parulekar, Wendy R

“…Conventional external beam radiotherapy is the standard palliative treatment for spinal metastases; however, complete response rates for pain are as low as…”
Get full text

Basal‐subtype bladder tumours show a ‘hot’ immunophenotype by Hodgson, Anjelica, Liu, Stanley K, Vesprini, Danny, Xu, Bin, Downes, Michelle R

“…Aims Basal and luminal molecular subgroups of muscle‐invasive urothelial carcinoma (UC) can be recognised by the use of immunohistochemical markers. Studies…”
Get full text

Endothelial perturbations and therapeutic strategies in normal tissue radiation damage by Korpela, Elina, Liu, Stanley K

“…Most cancer patients are treated with radiotherapy, but the treatment can also damage the surrounding normal tissue. Radiotherapy side-effects diminish…”
Get full text

Delta-Like Ligand 4-Notch Blockade and Tumor Radiation Response by LIU, Stanley K, BHAM, Saif A. S, FOKAS, Emmanouil, BEECH, John, IM, Jaehong, CHO, Song, HARRIS, Adrian L, MUSCHEL, Ruth J

Get full text

Reproducibility of PD-L1 immunohistochemistry interpretation across various types of genitourinary and head/neck carcinomas, antibody clones, and tissue types by Wang, Chiyun, Hahn, Elan, Slodkowska, Elzbieta, Eskander, Antoine, Enepekides, Danny, Higgins, Kevin, Vesprini, Danny, Liu, Stanley K., Downes, Michelle R., Xu, Bin

“…Programmed death-ligand 1 (PD-L1) expression by tumor cells is a mechanism for down-regulation of antitumor T-cell responses and is a target for immunotherapy…”
Get full text